Literature DB >> 24268513

Diagnostic performance of dual-source CT coronary angiography with and without heart rate control: systematic review and meta-analysis.

M Li1, G-M Zhang2, J-S Zhao3, Z-W Jiang4, Z-H Peng1, Z-T Jin5, G Sun6.   

Abstract

AIM: To investigate the diagnostic accuracy of dual-source computed tomography (DSCT) coronary angiography with and without the application of a β-blocker.
MATERIALS AND METHODS: An exact binomial rendition of the bivariate mixed-effects regression model was used to synthesize diagnostic test data.
RESULTS: The pooled sensitivity at the patient level was 0.98 [95% confidence intervals (CI): 0.97-0.99], and specificity 0.88 (95% CI: 0.84-0.91). The results showed that without heart rate control, the sensitivity and specificity at the patient level did not decrease (p = 0.27 and 0.56, respectively). At the artery level, no significant differences in sensitivity and specificity for studies with and without heart rate control were detected (p = 0.04 and 0.05, respectively). At the segment level, the specificity decreased without heart rate control (p = 0.03), whereas the sensitivity was not influenced (p = 0.63). The median radiation exposure was 2.6 mSv, with 1.6 mSv and 8 mSv for heart rate-controlled studies and uncontrolled studies, respectively.
CONCLUSIONS: DSCT coronary angiography without heart rate control has a similar excellent diagnostic performance at the patient level as that of heart rate control groups. However, controlling for heart rate to decrease radiation and to provide effective information for selecting the therapeutic strategy and risk stratification is recommended.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24268513     DOI: 10.1016/j.crad.2013.09.008

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  6 in total

Review 1.  Selecting a CT scanner for cardiac imaging: the heart of the matter.

Authors:  Maria A Lewis; Ana Pascoal; Stephen F Keevil; Cornelius A Lewis
Journal:  Br J Radiol       Date:  2016-07-07       Impact factor: 3.039

2.  Limits of the possible: diagnostic image quality in coronary angiography with third-generation dual-source CT.

Authors:  Marco M Ochs; Fabian Aus dem Siepen; Thomas Fritz; Florian Andre; Gitsios Gitsioudis; Grigorios Korosoglou; Sebastian Seitz; Yuriy Bogomazov; Christopher L Schlett; Roman Sokiranski; Andre Sommer; Friedemann Gückel; Matthias Brado; Hans-Ulrich Kauczor; Johannes Görich; Matthias G W Friedrich; Hugo A Katus; Sebastian J Buss
Journal:  Clin Res Cardiol       Date:  2017-02-06       Impact factor: 5.460

Review 3.  Computed tomography recent history and future perspectives.

Authors:  Jiang Hsieh; Thomas Flohr
Journal:  J Med Imaging (Bellingham)       Date:  2021-08-11

Review 4.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

5.  Safety, Efficacy, and Dose Protocol of Metoprolol for Heart Rate Reduction in Pediatric Outpatients Undergoing Cardiac CT Angiography.

Authors:  Mariana de Oliveira Nunes; Dawn R Witt; Susan A Casey; Larissa I Stanberry; David J Caye; Bradford J Chu; B Jana Lindberg; John R Lesser; B Kelly Han
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

6.  Diagnostic Accuracy of Dual-Source Computerized Tomography Coronary Angiography in Symptomatic Patients Presenting to a Referral Cardiovascular Center During Daily Clinical Practice.

Authors:  Arash Mahdavi; Ali Mohammadzadeh; Golsa Joodi; Mohammad Reza Tabatabaei; Farhad Sheikholeslami; Marzieh Motevalli
Journal:  Iran J Radiol       Date:  2016-02-29       Impact factor: 0.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.